More than two years after Mesoblast was poleaxed by the FDA’s rejection of its mesenchymal stem cell therapy for children with graft versus host disease (GvHD), the US reg
Catherine Isted has stepped down as chief executive of UK biotech ReNeuron with immediate effect, with board member and biopharma industry veteran Iain Ross appointed as executive chairman
A woman with HIV who received a stem cell transplant to treat acute myeloid leukaemia (AML) appears to have been cured of the infection according to US researchers.
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho